A court case we blogged a fair amount about even before it started (see the first post in 2008) appears to have finally come to an end in the DC Circuit Court's decision to uphold the ruling in favor of the FDA.
United States Court of Appeals
FOR THE DISTRICT OF COLUMBIA CIRCUIT
Decided February 4, 2014
UNITED STATES OF AMERICA,
REGENERATIVE SCIENCES, LLC, A CORPORATION, ET AL.,
Appeal from the United States District Court
for the District of Columbia
Dr. Centeno and I have had our differences but now is the time to recognize his contributions to the debate and, more importantly, to the field. We look forward to his future contributions to developing robust, cell-based treatments for patients.